Original Source(s)
Related Content
FDA Approves At-Home Starting Dose for Lecanemab
Patients may begin lecanemab-irmb treatment at home through self-administration or administration by a caregiver, according to the FDA.
July 13, 2026
-
3 min
Head-to-Head Trial in Relapsing MS
The phase 3 OVERLORD-MS trial compared 2 anti-CD20 therapies in previously untreated adults with newly diagnosed relapsing multiple sclerosis and recent inflammatory disease activity.
July 7, 2026
-
6 min
AI-Based Speech Analysis May Flag Cognitive Impairment
Machine-learning models trained on routine patient-physician conversations achieved similar performance in development and external validation cohorts in predicting cognitive impairment.
June 19, 2026
-
4 min
